News
Stay Connected with Dispex WhatsApp Support Group!
We’re pleased to see many of you joining and engaging with the community since ourlaunch on March 1st. Just this past week, one member shared, “I love this group –...
Dispex Live II: Part Two Summary
Class 2 Medicines Recall: Synalar GEL 30g, Synalar GEL 60g,(fluocinoline acetonide 0.025%) Reig Jofre UK,EL(25)A/16
Source: MHRA/ Gov.uk 8.4.25 It has been identified that the batches of Synalar Gel 30g and 60g listed in this notification contain a residual solvent (benzene) at a level exceeding...
Category M – Is there any respite in sight?
Inclisiran Update
From 1 April the reimbursement price of Inclisiran will increase to £60.00. In addition, the DHSC has classified that all drugs from Part VIIIC – Arrangements of Payment for Products...
All Change – Yet Again – Insights
By Dr Philip Koopowitz – Director Dispex As we come to the end of this financial year and start the new financial year, one could be forgiven if you thought...
We’re Hiring- Dispensing Tutor &Prescription Clerk Tutor
We are currently seeking an experienced Prescription Clerk and a seasoned Dispensing Lead to join our team. Dispensing Tutor We’re looking for an experienced, knowledgeable and friendly Lead Dispenser or...
Class 3 Medicines Recall: Urospir 50mg/5ml Oral Solution, EL(25)A/14
Source: MHRA/Gov.uk 31.3.25 Rosemont Pharmaceuticals Limited is recalling a single batch of Urospir 50mg/5ml Oral Solution (spironolactone) as a precautionary measure. The recall is due to errors in some of...
Class 2 Medicines Recall: Utrogestan Vaginal 200 mg Capsules (progesterone), EL(25)A/13
Source: MHRA/Gov.uk 1.4.25 Uni Health Distribution Ltd has informed the MHRA of a typographical error on the approved carton overlabel for certain batches of Utrogestan Vaginal 200 mg Capsules. The...
Handling Patient Concerns and Complaints with Professionalism
By Dispex Addressing patient concerns and complaints is a key responsibility for the Dispensary team. These interactions, though sometimes challenging, present valuable opportunities to improve patient satisfaction, strengthen trust, and...
Class 4 Medicines Defect Notification: Sirdupla 25 microgram/250 microgram per metered dose pressurised inhalation, suspension, EL(25)A/12
Source: MHRA/Gov.uk 31.3.25 Cross Healthcare Limited have informed the MHRA that there is a printing defect on the outer labels for the Sirdupla 25 microgram/250 microgram per metered dose pressurised...
Concession Price March 2025: Second Update
Update Dispex members can login here to see the updates all together in one place, and in alphabetical order. Looking to join Dispex, please click here.
